Methodological adjustment for seasonal variation nearly doubles nasal transcriptome analysis sensitivity

Accounting for seasonal shifts in nasal gene expression models increased the detection of disease-associated genes from 126 to 271, establishing a key methodological refinement for respiratory biomarker discovery.

Researchers analyzed RNA-sequencing data from nasal brushes of 361 asthma patients and 57 healthy controls within the ATLANTIS study cohort.

The analysis identified 1,731 genes that were differentially expressed between winter-spring (November 15 to May 14) and summer-autumn (May 15 to November 14) periods.

This seasonal transcriptomic signature was independently replicated in the 325-patient PIAMA cohort and found to be independent of asthma or allergy status.

Samples collected in the winter-spring period showed a significantly lower predicted proportion of ciliated cells (p = 0.005) and a higher proportion of basal cells (p = 0.04) compared to summer-autumn.

Incorporating the season of sample collection as a covariate in gene-expression models for asthma nearly doubled the number of detected differentially expressed genes from 126 to 271.

Transcriptome-based profiling of mucosal tissue is highly sensitive to environmental confounders, meaning uncorrected seasonal variations introduce significant background noise that can obscure disease-specific signals.

The change in ciliated and basal cell proportions indicates that seasonal variations represent actual physical remodeling of the nasal epithelium rather than transient metabolic shifts.

By demonstrating a near-doubling in assay sensitivity, the research provides a clear optimization path for transcriptomic biomarker discovery, which could reduce false negatives in clinical trials.

Biotechnology and pharmaceutical entities utilizing respiratory mucosal biomarkers in clinical trials can adopt seasonal covariates to improve signal-to-noise ratios.

This adjustment framework may help optimize clinical trials by potentially reducing required sample sizes or rescuing trial endpoints that would otherwise fail to achieve statistical significance due to uncorrected seasonal variance.

Adoption of seasonal adjustment protocols in clinical trial designs and dataset analysis plans for ongoing respiratory pipelines.

Studies investigating whether similar seasonal variation adjustments improve transcriptomic diagnostic sensitivity in other barrier tissues, such as skin or gut mucosa.